Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Mar 24
Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder…
15 Mar 24
Mental Health Center Initially Focused on Treatment of Patients with Substance Abuse Disorder
12 Mar 24
The results, published in the Journal of Neurosurgery, showed that the brain tissue temperature can be measured with…
05 Mar 24
The Vascular Covered Stent, which is under investigation, is a low-profile, self-expanding nitinol implant enclosed in polytetrafluoroethylene and…
01 Mar 24
The Varipulse Platform comprises the Varipulse Catheter, a variable-loop multielectrode catheter; Trupulse Generator, a multichannel PFA generator; and…
26 Feb 24
The investigator-sponsored clinical study, funded by the University of California San Diego Department of Anaesthesiology, obtained three major…
13 Feb 24
ReActiv8 is an implantable medical device designed to treat adults with intractable chronic low back pain (CLBP) due…
07 Feb 24
The Spectra and Alpha versions of WaveWriter SCS systems were already approved in the US, and expanded indication…
05 Feb 24
Cedars-Sinai Grants VRx Health Exclusive Licensing of Xaia Technology
02 Feb 24
Acquandas’ capability to manufacture miniaturised structures, such as micro-patterned Nitinol thin films, with high-structure resolution, geometrical complexity, and…